Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide
Year: 2012
Type: article
Abstract: OBJECTIVE: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. METHOD: Literature review with articles' selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. RESULTS AND CONCLUSIONS: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a first biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-inflammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient's vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated.
Authors: Licia Maria Henrique da Mota, Boris Afonso Cruz, Claiton Viegas Brenol, Ivanio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Victor Carioca de Freitas, Nilzio Antonio da Silva, Paulo Louzada-Júnior, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Geraldo da Rocha Castelar Pinheiro
Institutions: Universidade de Brasília, Biocor Institute, Universidade Federal do Rio Grande do Sul, Universidade de São Paulo, Universidade Federal de Santa Catarina, Hospital de Clínicas Universidade Federal do Paraná, Universidade Federal do Paraná, Universidade Estadual de Campinas (UNICAMP), Hospital de Clínicas da Unicamp, Universidade Federal do Ceará, Universidade Federal de Goiás, Hospital do Servidor Público Estadual, Universidade do Estado do Rio de Janeiro
Language: Portuguese
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, treatment guidelines, disease-modifying antirheumatic drugs, methotrexate, biologic DMARDs, TNF-alpha inhibitors, synthetic DMARDs, remission, extra-articular manifestations, cyclophosphamide, azathioprine, corticosteroids, nonsteroidal anti-inflammatory drugs, physiotherapy, family planning, comorbidities, vaccination
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W4319053946
